Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.

Khater F, Langlois S, Cassart P, Roy AM, Lajoie M, Healy J, Richer C, St-Onge P, Piché N, Perreault S, Cellot S, Marzouki M, Jabado N, Sinnett D.

Oncogene. 2018 Dec 21. doi: 10.1038/s41388-018-0623-3. [Epub ahead of print]

PMID:
30575814
2.

Gray Zone Lymphoma Arising in the Neck of a Teenager With a Germline Mutation in TP53.

Gatineau-Sailliant S, Turcotte K, Quintal MC, Turpin S, Champagne J, Petrella T, Roussy M, Cellot S, Bouron-Dal Soglio D.

J Pediatr Hematol Oncol. 2018 Oct 5. doi: 10.1097/MPH.0000000000001308. [Epub ahead of print]

PMID:
30299350
3.

Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.

Benadiba J, Ansari M, Krajinovic M, Vachon MF, Duval M, Teira P, Cellot S, Bittencourt H.

PLoS One. 2018 Apr 2;13(4):e0193862. doi: 10.1371/journal.pone.0193862. eCollection 2018.

4.

NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.

Roussy M, Bilodeau M, Jouan L, Tibout P, Laramée L, Lemyre E, Léveillé F, Tihy F, Cardin S, Sauvageau C, Couture F, Louis I, Choblet A, Patey N, Gendron P, Duval M, Teira P, Hébert J, Wilhelm BT, Choi JK, Gruber TA, Bittencourt H, Cellot S.

Genes Chromosomes Cancer. 2018 Jun;57(6):311-319. doi: 10.1002/gcc.22532. Epub 2018 Mar 28.

PMID:
29427526
5.

Synthetic human leukemia models: towards precision medicine.

Cellot S, Wilhelm BT, Barabé F.

Oncotarget. 2017 Nov 2;8(57):96480-96481. doi: 10.18632/oncotarget.22259. eCollection 2017 Nov 14. No abstract available.

6.

Identification of novel biomarkers for MLL-translocated acute myeloid leukemia.

Lagacé K, Barabé F, Hébert J, Cellot S, Wilhelm BT.

Exp Hematol. 2017 Dec;56:58-63. doi: 10.1016/j.exphem.2017.08.006. Epub 2017 Sep 11.

PMID:
28911906
7.

KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.

Khater F, Lajoie M, Langlois S, Healy J, Cellot S, Richer C, Beaulieu P, St-Onge P, Saillour V, Minden M, Marzouki M, Krajinovic M, Bittencourt H, Sinnett D.

Blood. 2017 Mar 23;129(12):1729-1732. doi: 10.1182/blood-2016-10-744219. Epub 2017 Jan 9. No abstract available.

8.

Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy.

Ceppi F, Duval M, Leclerc JM, Laverdiere C, Delva YL, Cellot S, Teira P, Bittencourt H.

PLoS One. 2016 Sep 15;11(9):e0160310. doi: 10.1371/journal.pone.0160310. eCollection 2016.

9.

Invasive Rothia infections in children with acute myeloid leukemia: A report from the Canadian infections in AML research group.

Wang JY, Brossard J, Cellot S, Dix D, Feusner J, Johnston DL, Lewis V, Mitchell D, Portwine C, Price V, Sung L, Ethier MC, Gillmeister B.

Pediatr Hematol Oncol. 2016 Aug;33(5):277-281. Epub 2016 Jun 17.

PMID:
27315594
10.

Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia.

Dix D, Aplenc R, Bowes L, Cellot S, Ethier MC, Feusner J, Gillmeister B, Johnston DL, Lewis V, Michon B, Mitchell D, Portwine C, Price V, Silva M, Stobart K, Yanofsky R, Zelcer S, Beyene J, Sung L.

Int J Cancer. 2016 Apr 1;138(7):1785-91. doi: 10.1002/ijc.29905. Epub 2015 Nov 17.

11.

Second Bacteremia During Antibiotic Treatment in Children With Acute Myeloid Leukemia: A Report From the Canadian Infections in Acute Myeloid Leukemia Research Group.

Tran TH, Yanofsky R, Johnston DL, Dix D, Gillmeister B, Ethier MC, Portwine C, Price V, Mitchell D, Cellot S, Lewis V, Zelcer S, Silva M, Michon B, Bowes L, Stobart K, Brossard J, Beyene J, Sung L.

J Pediatric Infect Dis Soc. 2014 Sep;3(3):228-33. doi: 10.1093/jpids/pit086. Epub 2014 Jan 15.

PMID:
26625386
12.

Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group.

Tran TH, Mitchell D, Dix D, Cellot S, Ethier MC, Gillmeister B, Hitzler J, Lewis V, Yanofsky R, Johnston DL, Portwine C, Price V, Zelcer S, Silva M, Michon B, Bowes L, Stobart K, Brossard J, Beyene J, Sung L.

Infect Agent Cancer. 2013 Dec 2;8(1):47. doi: 10.1186/1750-9378-8-47.

13.

Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.

Lewis V, Yanofsky R, Mitchell D, Dix D, Ethier MC, Gillmeister B, Johnston D, Michon B, Stobart K, Portwine C, Silva M, Cellot S, Price V, Bowes L, Zelcer S, Brossard J, Beyene J, Sung L.

Pediatr Infect Dis J. 2014 Feb;33(2):126-9. doi: 10.1097/INF.0000000000000058.

PMID:
24064558
14.

Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.

Price V, Portwine C, Zelcer S, Ethier MC, Gillmeister B, Silva M, Schindera C, Yanofsky R, Mitchell D, Johnston DL, Lewis V, Dix D, Cellot S, Michon B, Bowes L, Stobart K, Brossard J, Beyene J, Sung L.

Pediatr Infect Dis J. 2013 Jun;32(6):610-3. doi: 10.1097/INF.0b013e31828690a4.

PMID:
23838731
15.

RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity.

Cellot S, Hope KJ, Chagraoui J, Sauvageau M, Deneault É, MacRae T, Mayotte N, Wilhelm BT, Landry JR, Ting SB, Krosl J, Humphries K, Thompson A, Sauvageau G.

Blood. 2013 Aug 29;122(9):1545-55. doi: 10.1182/blood-2013-04-496281. Epub 2013 Jun 18.

16.

Infections in pediatric acute promyelocytic leukemia: from the Canadian infections in acute myeloid leukemia research group.

Cellot S, Johnston D, Dix D, Ethier MC, Gillmeister B, Mitchell D, Yanofsky R, Lewis V, Portwine C, Price V, Zelcer S, Silva M, Bowes L, Michon B, Stobart K, Brossard J, Beyene J, Sung L.

BMC Cancer. 2013 Jun 4;13:276. doi: 10.1186/1471-2407-13-276.

17.

Infectious events prior to chemotherapy initiation in children with acute myeloid leukemia.

Portwine C, Mitchell D, Johnston D, Gillmeister B, Ethier MC, Yanofsky R, Dix D, Cellot S, Lewis V, Price V, Silva M, Zelcer S, Bowes L, Michon B, Stobart K, Brossard J, Beyene J, Sung L.

PLoS One. 2013 Apr 26;8(4):e61899. doi: 10.1371/journal.pone.0061899. Print 2013.

18.

Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia.

Ramsey JM, Kettyle LM, Sharpe DJ, Mulgrew NM, Dickson GJ, Bijl JJ, Austin P, Mayotte N, Cellot S, Lappin TR, Zhang SD, Mills KI, Krosl J, Sauvageau G, Thompson A.

Stem Cells. 2013 Jul;31(7):1434-45. doi: 10.1002/stem.1398.

19.

Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.

Dix D, Cellot S, Price V, Gillmeister B, Ethier MC, Johnston DL, Lewis V, Michon B, Mitchell D, Stobart K, Yanofsky R, Portwine C, Silva M, Bowes L, Zelcer S, Brossard J, Traubici J, Allen U, Beyene J, Sung L.

Clin Infect Dis. 2012 Dec;55(12):1608-14. doi: 10.1093/cid/cis774. Epub 2012 Sep 5.

PMID:
22955431
20.

A role for GPx3 in activity of normal and leukemia stem cells.

Herault O, Hope KJ, Deneault E, Mayotte N, Chagraoui J, Wilhelm BT, Cellot S, Sauvageau M, Andrade-Navarro MA, Hébert J, Sauvageau G.

J Exp Med. 2012 May 7;209(5):895-901. doi: 10.1084/jem.20102386. Epub 2012 Apr 16.

Supplemental Content

Loading ...
Support Center